Metformin in neoadjuvant systemic therapy of breast cancer patients with metabolic syndrome

Metformin in neoadjuvant systemic therapy of breast cancer patients with metabolic syndrome

Background: The aim of this prospective randomized trial was to investigate the influence of metformin on the effectiveness of neoadjuvant systemic therapy in breast cancer patients with metabolic syndrome. Patients and methods: The study included 72 patients (from 31 to 77 years of age) who receive...

Full description

Bibliographic Details
Main Authors: Liubota Roman, Cheshuk Valeriy, Zotov Olexyy, Vereshchako Roman, Anikusko Mykola, Liubota Iryna, Gur'yanov Vitaliy
Format: Article
Language:English
Published: Institute of Oncology, Sremska Kamenica, Serbia 2018-01-01
Series:Archive of Oncology
Subjects:
breast cancer
metabolic syndrome
neoadjuvant systemic therapy
metformin
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/0354-7310/2018/0354-73101801001L.pdf

Similar Items

Similar Items